We are live on
!
Find out more
Capital Analysts LLC Portfolio holdings
AUM
$4.34B
Turnover
9.37%
1-Year Est. Return
17.55%
This Fund
S&P 500
This Quarter
Est. Return
+10.34%
1 Year Est. Return
+17.55%
3 Year Est. Return
+51.26%
5 Year Est. Return
+53.67%
10 Year Est. Return
+179.02%
AUM
$1.14B
AUM Growth
+$86.6M
(+8.2%)
Cap. Flow
-$11.7M
Cap. Flow
% of AUM
-1.02%
Top 10 Holdings %
Top 10 Hldgs %
43.01%
Holding
842
New
85
Increased
236
Reduced
205
Closed
102
Avg Time Held
2.8
years
Top 10 Avg Time Held
2.6
years
Top 20 Avg Time Held
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xtrackers USD High Yield Corporate Bond ETF
HYLB
|
+$22.9M |
| 2 |
Fidelity Low Volatility Factor ETF
FDLO
|
+$5.86M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$5.76M |
| 4 |
Target
TGT
|
+$4.68M |
| 5 |
Walt Disney
DIS
|
+$2.75M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
|
+$13.7M |
| 2 |
State Street SPDR S&P Global Infrastructure ETF
GII
|
+$8.69M |
| 3 |
State Street SPDR US Large Cap Low Volatility Index ETF
LGLV
|
+$6.87M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$4.19M |
| 5 |
Automatic Data Processing
ADP
|
+$3.97M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 70.31% |
| 2 | Technology | 6.49% |
| 3 | Healthcare | 4.8% |
| 4 | Financials | 4.08% |
| 5 | Industrials | 2.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Synopsys
SNPS
$89.7B
| $1.95M | 0.17% |
7,527
+230
| +3% | +$53K |
2018 Q1
11 quarters
|
|
102
Vanguard Total Bond Market
BND
$163B
| $1.95M | 0.17% |
22,091
+2,557
| +13% | +$225K |
2019 Q4
4 quarters
|
|
103
Sherwin-Williams
SHW
$81.8B
| $1.94M | 0.17% |
7,938
+165
| +2% | +$39.1K |
2014 Q4
24 quarters
|
|
104
SS&C Technologies
SSNC
$19.8B
| $1.9M | 0.17% |
26,078
+1,018
| +4% | +$68.2K |
2019 Q1
7 quarters
|
|
105
Bank of America
BAC
$362B
| $1.89M | 0.17% |
62,502
+4,723
| +8% | +$127K |
2017 Q2
14 quarters
|
|
106
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.46B
| $1.84M | 0.16% |
35,677
+4,082
| +13% | +$211K |
2018 Q4
8 quarters
|
|
107
Danaher
DHR
$163B
| $1.82M | 0.16% |
9,219
-2,077
| -18% | -$416K |
2018 Q4
8 quarters
|
|
108
Equinix
EQIX
$98.3B
| $1.8M | 0.16% |
2,525
+78
| +3% | +$58.1K |
2017 Q2
14 quarters
|
|
109
McDonald's
MCD
$172B
| $1.8M | 0.16% |
8,402
-868
| -9% | -$189K |
2015 Q4
20 quarters
|
|
110
Amgen
AMGN
$235B
| $1.8M | 0.16% |
7,815
+434
| +6% | +$100K |
2017 Q2
14 quarters
|
|
111
Blackrock
BLK
$174B
| $1.79M | 0.16% |
2,482
-417
| -14% | -$277K |
2013 Q2
30 quarters
|
|
112
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.52B
| $1.77M | 0.16% |
29,046
-1,492
| -5% | -$87K |
2015 Q3
21 quarters
|
|
113
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $1.77M | 0.16% |
+89,700
| New | +$1.67M |
2020 Q4
0 quarters
|
|
114
State Street SPDR S&P Dividend ETF
SDY
$21.4B
| $1.77M | 0.16% |
16,667
-344
| -2% | -$34.8K |
2013 Q2
30 quarters
|
|
115
Eaton
ETN
$156B
| $1.75M | 0.15% |
14,570
-1,901
| -12% | -$215K |
2019 Q1
7 quarters
|
|
116
Citizens Financial Group
CFG
$26.7B
| $1.74M | 0.15% |
48,684
-4,472
| -8% | -$140K |
2016 Q1
19 quarters
|
|
117
DELISTED
Splunk Inc
SPLK
| $1.73M | 0.15% |
10,206
-981
| -9% | -$188K |
2017 Q4
12 quarters
|
|
118
Thermo Fisher Scientific
TMO
$258B
| $1.72M | 0.15% |
3,694
-1,035
| -22% | -$485K |
2015 Q4
20 quarters
|
|
119
Pfizer
PFE
$168B
| $1.72M | 0.15% |
46,700
-5,814
| -11% | -$213K |
2013 Q2
30 quarters
|
|
120
FMC
FMC
$874M
| $1.71M | 0.15% |
14,878
+677
| +5% | +$75.4K |
2018 Q2
10 quarters
|
|
121
Fiserv Inc
FISV
$25.1B
| $1.71M | 0.15% |
14,995
+707
| +5% | +$76.2K |
2020 Q3
1 quarter
|
|
122
Analog Devices
ADI
$196B
| $1.7M | 0.15% |
11,521
-1,417
| -11% | -$188K |
2017 Q2
14 quarters
|
|
123
MetLife
MET
$63.7B
| $1.69M | 0.15% |
35,914
-2,707
| -7% | -$117K |
2013 Q2
30 quarters
|
|
124
Paychex
PAYX
$39.4B
| $1.69M | 0.15% |
18,092
-1,751
| -9% | -$155K |
2015 Q3
21 quarters
|
|
125
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.93B
| $1.69M | 0.15% |
10,033
+45
| +0.5% | +$7.3K |
2019 Q1
7 quarters
|
|
Similar funds
ZP
AIIMS
Capital Analysts LLC's Q4 2020 Portfolio in Review
As of Q4 2020, Capital Analysts LLC held 842 positions worth $1.14B, up 8.2% from $1.05B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Capital Analysts LLC's Q4 2020 filing shows 85 new, 236 increased, 205 reduced and 102 closed positions. Its largest new stake was Xtrackers USD High Yield Corporate Bond ETF: 582,649 shares worth $23.3M. The largest sale was iShares 0-5 Year High Yield Corporate Bond ETF, an estimated $13.7M.
By sector, the portfolio is most concentrated in Miscellaneous at 70% of assets, up from 69% a quarter earlier, followed by Technology and Healthcare.
- Capital Analysts LLC's largest Q4 2020 buy was Xtrackers USD High Yield Corporate Bond ETF: 582,649 shares worth $23.3M.
- Capital Analysts LLC added most to Fidelity Low Volatility Factor ETF in Q4 2020, an estimated $5.86M increase.
- Capital Analysts LLC's biggest Q4 2020 reduction was iShares 0-5 Year High Yield Corporate Bond ETF, cutting an estimated $13.7M.
- Capital Analysts LLC fully exited State Street SPDR US Large Cap Low Volatility Index ETF in Q4 2020, selling an estimated $6.87M.
- Capital Analysts LLC's ten largest holdings make up 43% of its $1.14B portfolio in Q4 2020.
- Capital Analysts LLC opened 85 new positions and closed 102 in Q4 2020.
- Capital Analysts LLC's portfolio value rose 8.2% quarter-over-quarter to $1.14B.
Based on Capital Analysts LLC's 13F filing for Q4 2020, filed 16 Feb 2021.